Man Group plc Purchases New Position in Aveanna Healthcare Holdings Inc. $AVAH

Man Group plc purchased a new stake in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) in the second quarter, Holdings Channel.com reports. The firm purchased 121,652 shares of the company’s stock, valued at approximately $1,043,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in AVAH. Vanguard Group Inc. lifted its stake in shares of Aveanna Healthcare by 38.0% during the 4th quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock valued at $45,564,000 after buying an additional 1,535,351 shares in the last quarter. Parkman Healthcare Partners LLC purchased a new position in Aveanna Healthcare in the 2nd quarter valued at approximately $6,123,000. Dimensional Fund Advisors LP raised its holdings in Aveanna Healthcare by 49.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,334,374 shares of the company’s stock valued at $8,593,000 after acquiring an additional 441,707 shares during the period. Segall Bryant & Hamill LLC raised its holdings in Aveanna Healthcare by 425.8% during the 1st quarter. Segall Bryant & Hamill LLC now owns 163,966 shares of the company’s stock valued at $1,056,000 after acquiring an additional 132,779 shares during the period. Finally, NFJ Investment Group LLC purchased a new stake in shares of Aveanna Healthcare during the second quarter worth $2,682,000. 87.96% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have recently weighed in on AVAH shares. Truist Financial lifted their price target on Aveanna Healthcare from $11.00 to $15.00 and gave the company a “hold” rating in a research report on Monday, August 24th. Raymond James Financial increased their price objective on Aveanna Healthcare from $13.00 to $15.00 and gave the stock a “strong-buy” rating in a report on Friday, August 14th. UBS Group raised their target price on Aveanna Healthcare from $8.00 to $13.00 and gave the stock a “neutral” rating in a research note on Friday, August 14th. BMO Capital Markets upped their price target on Aveanna Healthcare from $10.00 to $14.00 and gave the company an “outperform” rating in a research report on Friday, August 14th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Thursday, July 2nd. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, Aveanna Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $13.50.

Insiders Place Their Bets

In other Aveanna Healthcare news, insider Edwin C. Reisz sold 50,000 shares of the company’s stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $11.50, for a total transaction of $575,000.00. Following the completion of the sale, the insider directly owned 1,397,897 shares in the company, valued at $16,075,815.50. This represents a 3.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Jeff Shaner sold 90,000 shares of the firm’s stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $11.50, for a total value of $1,035,000.00. Following the transaction, the chief executive officer directly owned 2,561,972 shares in the company, valued at $29,462,678. This trade represents a 3.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 59,904,505 shares of company stock valued at $649,301,514 over the last three months. 5.30% of the stock is currently owned by company insiders.

Aveanna Healthcare Stock Down 1.9%

Shares of NASDAQ AVAH opened at $13.20 on Thursday. Aveanna Healthcare Holdings Inc. has a one year low of $5.93 and a one year high of $14.00. The company has a debt-to-equity ratio of 4.47, a current ratio of 1.16 and a quick ratio of 1.16. The firm’s 50 day simple moving average is $10.49 and its two-hundred day simple moving average is $8.23. The stock has a market capitalization of $2.88 billion, a P/E ratio of 10.73, a PEG ratio of 0.85 and a beta of 1.97.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings data on Thursday, August 13th. The company reported $0.22 earnings per share for the quarter, topping analysts’ consensus estimates of $0.17 by $0.05. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. The firm had revenue of $670.48 million during the quarter, compared to analyst estimates of $638.61 million. As a group, analysts expect that Aveanna Healthcare Holdings Inc. will post 0.75 EPS for the current fiscal year.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.